This is a multicenter trial of the Optune device to examine the feasibility and to describe the device-related toxicity in children in Stratum 1 and efficacy of concurrent Optune and standard focal radiation therapy in Stratum 2.
Study Details
Internal Title:
PBTC-048
PCH IRB Number:
IRB-23-411
Clinical Trials Government Identifier:
NCT03033992
Diagnoses & Treatments:
High-grad glioma, DIPG, recurrent/refractory ependymoma, Optune, TTFields, cancer
Study Type:
Investigational Device
Eligibility:
Diagnosis for respective stratum, Stratum 1: Patient must be = 5 but = 21 years of age, Stratum 2: Patient must be = 3 but = 21 years of age
Enrollment Status:
Open
Phase:
I/II